HUP0302436A2 - Antidepresszáns gyógyszerek által kiváltott szexuális rendellenességek kezelése apomorfinnal - Google Patents

Antidepresszáns gyógyszerek által kiváltott szexuális rendellenességek kezelése apomorfinnal

Info

Publication number
HUP0302436A2
HUP0302436A2 HU0302436A HUP0302436A HUP0302436A2 HU P0302436 A2 HUP0302436 A2 HU P0302436A2 HU 0302436 A HU0302436 A HU 0302436A HU P0302436 A HUP0302436 A HU P0302436A HU P0302436 A2 HUP0302436 A2 HU P0302436A2
Authority
HU
Hungary
Prior art keywords
apomorphine
treatment
sexual dysfunction
induced sexual
patient
Prior art date
Application number
HU0302436A
Other languages
English (en)
Inventor
Renee J. Perdok
Dustin D. Ruff
Original Assignee
Tap Pharmaceutical Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceutical Products Inc. filed Critical Tap Pharmaceutical Products Inc.
Publication of HUP0302436A2 publication Critical patent/HUP0302436A2/hu
Publication of HUP0302436A3 publication Critical patent/HUP0302436A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A jelen találmány szexuális rendellenességek kezelésére szolgálóeljárásra vonatkozik az erre rászoruló betegben, aki antidepresszánsgyógyszert szed, amely eljárás magában foglalja az apomorfin vagy egygyógyszerészetileg elfogadható sója terápiásan hatékony mennyiségénekbeadását az említett betegnek. Az eljárás antidepresszánsokat, mintpl. triciklusos antidepresszánsokat, monoaminoxidáz-inhibitorokat vagyszelektív szerotoninfelvétel-inhibitorokat szedő betegek esetébenhasznosítható. Ó
HU0302436A 2000-11-15 2001-11-14 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine HUP0302436A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24903100P 2000-11-15 2000-11-15
PCT/US2001/043933 WO2002039879A2 (en) 2000-11-15 2001-11-14 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine

Publications (2)

Publication Number Publication Date
HUP0302436A2 true HUP0302436A2 (hu) 2003-11-28
HUP0302436A3 HUP0302436A3 (en) 2004-10-28

Family

ID=22941748

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302436A HUP0302436A3 (en) 2000-11-15 2001-11-14 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine

Country Status (18)

Country Link
US (1) US6528521B2 (hu)
EP (1) EP1341536A4 (hu)
JP (1) JP2004513899A (hu)
KR (1) KR20030077538A (hu)
CN (1) CN1486183A (hu)
AU (1) AU2002235129A1 (hu)
BG (1) BG107874A (hu)
BR (1) BR0111982A (hu)
CA (1) CA2429047A1 (hu)
CZ (1) CZ20031540A3 (hu)
HU (1) HUP0302436A3 (hu)
IL (1) IL155667A0 (hu)
MX (1) MXPA03004288A (hu)
NO (1) NO20032189L (hu)
PL (1) PL361875A1 (hu)
SK (1) SK7422003A3 (hu)
WO (1) WO2002039879A2 (hu)
ZA (1) ZA200303471B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
CA2522231A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
WO2005023767A2 (en) 2003-09-10 2005-03-17 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0721394D0 (en) * 2007-10-31 2007-12-12 Vectura Group Plc Compositions for trating parkinson's disease
WO2012083269A1 (en) 2010-12-16 2012-06-21 Cynapsus Therapeutics, Inc. Sublingual films
WO2014105655A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
CA3019769C (en) * 2015-04-21 2021-10-12 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
US11382867B2 (en) 2018-01-18 2022-07-12 Leukos Biotech, S. L. Apomorphine-palmitic acid cocrystal solid particle crystalline form
US11717495B2 (en) * 2020-03-16 2023-08-08 Vella Bioscience, Inc. Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
CN115671106B (zh) * 2021-07-21 2024-03-19 广州新济药业科技有限公司 吗啡的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
ES2239369T3 (es) 1993-03-26 2005-09-16 Franciscus Wilhelmus Henricus Maria Merkus Composiciones farmaceuticas para administracion intranasal de dihidroergotamina.
PT758895E (pt) 1994-04-22 2000-05-31 Univ Kingston Formas de dosagem sublingual contendo apomorfina para uso no tratamento da disfuncao erectil
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DK0914097T3 (da) 1996-03-12 2002-04-29 Alza Corp Sammensætning og doseringsform omfattende opioid antagonist
US5897864A (en) 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
AU731349B2 (en) * 1996-12-02 2001-03-29 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating sexual dysfunctions
US5945117A (en) 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain

Also Published As

Publication number Publication date
CZ20031540A3 (cs) 2004-05-12
BG107874A (bg) 2004-01-30
US20020115683A1 (en) 2002-08-22
MXPA03004288A (es) 2004-09-10
IL155667A0 (en) 2003-11-23
EP1341536A2 (en) 2003-09-10
KR20030077538A (ko) 2003-10-01
US6528521B2 (en) 2003-03-04
BR0111982A (pt) 2003-10-28
JP2004513899A (ja) 2004-05-13
EP1341536A4 (en) 2007-08-01
CN1486183A (zh) 2004-03-31
ZA200303471B (en) 2004-08-06
SK7422003A3 (en) 2004-01-08
PL361875A1 (en) 2004-10-04
WO2002039879A2 (en) 2002-05-23
NO20032189D0 (no) 2003-05-14
AU2002235129A1 (en) 2002-05-27
NO20032189L (no) 2003-07-08
WO2002039879A3 (en) 2002-07-25
HUP0302436A3 (en) 2004-10-28
CA2429047A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
NO2012015I2 (no) Dapoxetine
HUP0302436A2 (hu) Antidepresszáns gyógyszerek által kiváltott szexuális rendellenességek kezelése apomorfinnal
BR0316753A (pt) Método de tratamento para disfunção sexual
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
HUP0103408A2 (hu) Dopamin-újrafelvétel inhibitorokat tartalmazó kompozíciók és az inhibitorok alkalmazási eljárásai
HUP0102511A2 (hu) Kombinált gyógykezelés bipoláris betegségek kezelésére
DE602006021444D1 (de) Therapie zur behandlung der überaktiven blase
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
BRPI0414347A (pt) associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade
HUP0402619A2 (hu) Norepinefrin re-uptake inhibitorok alkalmazása a megértési nehézségek kezelésére használható gyógyszer előállítására
PA8517701A1 (es) Combinacion de secretagogos de hormona del crecimiento y antidepresivos
HUP0402358A2 (hu) Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
JP2007505156A5 (hu)
HUP0301578A2 (hu) Szubsztituált nitrált katechinek, alkalmazásuk, valamint ilyen vegyületeket tartalmazó gyógyászati készítmények
KR100709159B1 (ko) 섬유근육통 및 기타 관련 장애를 위한 가바펜틴 유사체
Lee et al. Vardenafil inhibiting parasympathetic function of tracheal smooth muscle
AR037315A1 (es) Uso de la apomorfina en la fabricacion de un medicamento util para la disfuncion sexual inducida por drogas antidepresivas
TH68160A (th) การรักษาการเสื่อมหน้าที่ทางเพศที่เกิดจากยาต้านอาการซึมเศร้าด้วยอะโพมอร์ฟีน
UY27037A1 (es) Composición de apomorfina para tratar la disfunción sexual con niveles específicos de concentración en plasma
BR9806330A (pt) Novo uso do grupo de formulações farmacêuticas, conhecidos como drogas antidepressivas, para o novo uso do tratamento da ejaculação precoce
EA004801B1 (ru) Способ лечения болезни пейрони

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees